Drug–drug interaction through molecular structure similarity analysis

BACKGROUND: Drug–drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for patient safety but is very challenging. Currently, the US Food and Drug Administration and pharmaceutical companies are showing great interest in the development of improved tool...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Vilar, Santiago, Harpaz, Rave, Uriarte, Eugenio, Santana, Lourdes, Rabadan, Raul, Friedman, Carol
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Group 2012
Ämnen:
Research and Applications
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534468/
https://ncbi.nlm.nih.gov/pubmed/22647690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/amiajnl-2012-000935
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk